Evolent Health, Inc. announced the nomination of Shawn Guertin for election to its Board of Directors at the annual meeting of stockholders scheduled for June 5, 2025. Mr. Guertin brings nearly 40 years of actuarial, financial, and management experience in the insurance and healthcare sectors.
Mr. Guertin most recently served as Executive Vice President and Chief Financial Officer for CVS Health Corporation from May 2021 to October 2023. His nomination follows a search process by the Board's Nominating and Governance Committee to refresh an independent director position.
If elected, Mr. Guertin would be the sixth new independent director added to the Board in the past four years, reflecting the Board's focus on strong corporate governance. He is expected to bring valuable expertise in driving growth and profitability within the healthcare industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.